United Kingdom Model for End-Stage Liver Disease (UKELD)
ورودیهای بالینی بیمار
حداقل ۰.۸ — حداکثر ۱۰ • واحد: ratio
حداقل ۳۰ — حداکثر ۸۰۰ • واحد: µmol/L
حداقل ۵ — حداکثر ۱۰۰۰ • واحد: µmol/L
حداقل ۱۲۰ — حداکثر ۱۵۰ • واحد: mmol/L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Below Transplant Threshold0–48
- Transplant Eligible49–59
- High Priority Transplant60–100
The United Kingdom Model for End-Stage Liver Disease (UKELD) calculates predicting mortality in end-stage liver disease patients for liver transplant planning. Key inputs include inr. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Predicts mortality in end-stage liver disease patients for liver transplant planning. Developed specifically for UK population to determine eligibility for liver transplantation and estimate patient prognosis.
Clinical Indication
The United Kingdom Model for End-Stage Liver Disease (UKELD) is indicated for bedside clinical practice to support Predicts mortality in end-stage liver disease patients for liver transplant planning. Developed specifically for UK population to determine eligibility for liver transplantation and estimate patient prognosis.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration. Clinical exclusion: Excludes patients with hepatocellular carcinoma, who may qualify for transplantation through other criteria.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.
UKELD Score = 5.395 × ln(INR) + 1.485 × ln(creatinine, µmol/L) + 3.13 × ln(bilirubin, µmol/L) - 81.565 × ln(sodium, mmol/L) + 435
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| inr | float | Yes | International Normalized Ratio (INR) - measure of blood clotting time(ratio) |
| creatinine_umol_l | float | Yes | Serum creatinine concentration in micromoles per liter(µmol/L) |
| bilirubin_umol_l | float | Yes | Serum bilirubin concentration in micromoles per liter(µmol/L) |
| sodium_mmol_l | float | Yes | Serum sodium concentration in millimoles per liter(mmol/L) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–48 | Below Transplant Threshold | Low mortality risk |
| 49–59 | Transplant Eligible | Moderate to high mortality risk |
| 60–100 | High Priority Transplant | Very high mortality risk |
Evidence-Based References (EBM)
- Neuberger J, Gimson A, Davies M, Akyol M, O'Grady J, Burroughs A, Hudson M. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut. 2008;57(2):252-7.
- Barber K, Madden S, Allen J, Collett D, Neuberger J, Gimson A. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation. 2011;92(4):469-76.